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BACKGROUND: Countries across the globe have mobilized their armed forces in response to 
COVID-19, placing these military first-responders at increased risk for viral exposure. Humoral 
responses to SARS-CoV-2 among military personnel serve as biomarkers of infection and 
provide a basis for disease surveillance and recognition of work-related risk factors. 
METHODS: Enzyme-linked immunosorbent assays (ELISA) were used to measure SARS-
CoV-2 spike antigen-specific IgG in serum obtained from N=995 US Army and Air National 
Guard soldiers between April and June 2020. Occupational information, e.g., military operating 
specialty (MOS) codes, and demographic data were obtained via questionnaire. Plaque assays 
with live SARS-CoV-2 were used to assess serum neutralizing capacity for limited subjects 
(N=12). 
RESULTS: The SARS-CoV-2 IgG seropositivity rate among the study population was 10.3% 
and significantly associated with occupation and demographics. Odds ratios were highest for 
those working in MOS 2T – Transportation (3.6; 95% CI 0.7 – 18) and 92F – Fuel Specialist 
(Ground and Aircraft) (6.8; 95% CI 1.5 – 30), as well as black race (2.2; 95% CI 1.2 – 4.1), 
household size ≥ 6 (2.5; 95% CI 1.3 – 4.6) and known COVID-19 exposure (2.0; 95% CI 1.2 – 
3.3). Seropositivity tracked along major interstate highways, clustered near the international 
airport and the New York City border. SARS-CoV-2 spike IgG serum exhibited low to moderate 
SARS-CoV-2 neutralizing capacity with IC50s ranging from 1:15 to 1:280. In limited follow-up 
testing SARS-CoV-2 serum IgG levels remained elevated up to 7 months. 
CONCLUSION: The data highlight increased SARS-CoV-2 seroprevalence among National 
Guard soldiers responding to the COVID-19 pandemic compared to the local civilian population 
in association with the transportation – related occupations and specific demographics.  
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The armed forces of most countries play a vital role in responding to regional, national 
and local disasters, as well as emergencies and military threats. These men and women are often 
part-time military personnel, trained to respond in a moment’s notice. In the United States, these 
military personnel belong to the National Guard, reporting both to state leadership and federal 
leadership. Countries across the globe have mobilized their armed forces in response to the 
COVID-19 pandemic, placing them at increased risk for viral exposure (1-3). COVID-19 
outbreaks among military personnel highlight their susceptibility to SARS-CoV-2 infection and 
the importance of disease surveillance of this critical workforce (4-8).   
The National Guard of the United States (US) military is the armed forces responsible for 
protecting civilian populations, with each state/territory maintaining its own troops (army and 
air).  To assist in the COVID-19 pandemic, governors across all 50 states, Puerto Rico, Guam, 
the U.S. Virgin Islands, and Washington D.C. deployed their local Army/Air National Guard 
Units (9). At the height of deployment levels in May 2020 nearly 50,000 troops were activated 
for missions that included sorting and delivering medical supplies, cleaning high-traffic public 
spaces, food distribution, assisting nursing homes with testing, and supporting local medical 
organizations and hospitals. The deadline for National Guard deployments originally set to end 
Aug. 21, 2020 was extended through March 31, 2021 in forty-eight states and three territories 
(10). 
In Connecticut, USA, a state where SARS-CoV-2 was detected early during the 
pandemic, the National Guard was at the forefront of anti-COVID-19 efforts. To help ensure 
workforce protection, the state’s military leadership adopted a proactive stance toward 
surveillance via serology. Data obtained from N=955 soldiers, airmen, and militia members who 
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volunteered to participate in COVID-19 antibody testing during April-June 2020 are analyzed 
here. 
The present study results provide insight into the prevalence and localized distribution of 
COVID-19 cases early in the pandemic. The data identify significant associations of viral-
specific serum IgG with demographics as well as job title as defined by military occupational 
specialty (MOS) code. MOS codes (usually starting with a specific number-letter combination) 
are used by the US military to define jobs with similar duties and functions. We further evaluated 
viral neutralizing capacity of serum from a subset of subjects and the duration of SARS-CoV-2 
serum IgG in limited follow-up samples available up to 7 months after the initial test. The 






Human subjects. Volunteers from the CT Army and Air National Guard were recruited to 
have their SARS-CoV-2 spike antigen-specific antibody levels tested. Subjects provided 3cc of 
blood by venipuncture using vacutainer tubes (Becton Dickinson; Franklin Lake, NJ); serum was 
separated and stored frozen at -80oC until tested by enzyme linked immunosorbent assay 
(ELISA). The studies were reviewed, and ethical approval was given by the Yale University 
Institutional Review Board. All participants provided informed verbal consent.  
ELISA methods. ELISAs were performed as previously described with minor 
modifications (11, 12). In short, Triton X-100 and RNase A were added to serum samples at final 
concentrations of 0.5% and 0.5mg/ml respectively and incubated at room temperature (RT) for 
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30 minutes before use to reduce risk from any potential virus in serum. 96-well MaxiSorp plates 
(ThermoFisher, Waltham, MA) were coated with 50 μL/well of recombinant SARS Cov-2 
ectodomain (Sino Biologicals; Wayne, PA) at a concentration of 1 μg/ml in NaCO3 buffer pH 
9.6 and incubated overnight at 4°C. The coating buffer was removed, and plates were incubated 
for 1h at RT with 200 μL of blocking solution (PBS with 3% milk powder). Serum was diluted 
1:100 in dilution solution (PBS with 0.05% Tween20, 1% milk powder) and 100 μL of diluted 
serum was added for one hour at RT. Plates were washed three times with PBS-T (PBS with 
0.1% Tween-20) and 50 μL of HRP anti-Human IgG Antibody (Pharmingen/BD Biosiences, San 
Jose, CA) or HRP anti-human IgA (BioLegend, San Diego, CA) were added at 1:2000-fold 
dilution. After 1 hour of incubation at RT, plates were washed three times with PBS-T. Plates 
were developed with 100 μL of TMB Substrate Reagent Set (BD Biosciences, San Jose, CA) and 
the reaction was stopped when an internal pooled serum positive control sample reached an OD 
of 1.0 at 650 nm, by the addition of 2 N sulfuric acid. Plates were then read at a wavelength of 
450 nm with reference wavelength calibration (650nm).  
Cell lines and virus. VeroE6 kidney epithelial cells from ATTC were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 1% sodium pyruvate (NEAA) 
and 5% fetal bovine serum (FBS) at 37°C and 5% CO2. SARS-CoV-2, strain USA-WA1/2020, 
was obtained from BEI Resources (#NR-52281) and amplified in VeroE6 cells. Cells were 
infected at a multiplicity of infection level of 0.01 for forty three days to generate a working 
stock. Culture supernatant was clarified by centrifugation (450g × 5min) and filtered through a 
0.45-micron filter. The pelleted virus was then resuspended in PBS then aliquoted for storage at 
−80°C. Viral titers were measured by standard plaque assay using Vero E6 cells. Briefly, 300 µL 
of serial fold virus dilutions were used to infect Vero E6 cells in MEM supplemented NaHCO3, 
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4% FBS 0.6% Avicel RC-581. Plaques were resolved at 48h post infection by fixing in 10% 
formaldehyde for 1h followed by with 0.5% crystal violet in 20% ethanol staining. Plates were 
rinsed in water to plaques enumeration. All experiments were performed in a biosafety level 3 
with the Yale Environmental Health and Safety office approval.  
Neutralization assay. Study subject sera were heat treated for 30m at 56°C. Sixfold 
serially diluted plasma, from 1:3 to 1:2430 were incubated with SARS-CoV-2 for 1 hour at 
37°C. The mixture was subsequently incubated with Vero E6 cells in a 6-well plate for 1 hour. 
Then, cells were overlayed with MEM supplemented NaHCO3, 4% FBS 0.6% Avicel mixture. 
Plaques were resolved at 40 hours post infection by fixing in 10% formaldehyde for 1 hour 
followed by staining in 0.5% crystal violet. All experiments were performed in parallel with 
negative controls sera, in aa established viral concentration to generate 120-150 plaques/well.  
Statistical Methods. Descriptive statistics (means and standard deviations for continuous 
variables and percentages for categorical variables) of both predictor and outcome variables for 
the entire study population were calculated.  Linear regression models were developed to model 
the loge of spike antigen IgG response level as the data had a log normal distribution.  
Unadjusted (bivariate) models were developed for each predictor.  Additionally, a parsimonious 
model was determined utilizing multivariate regression modeling incorporating a backward 
selection strategy with significance level-to-stay specified as α=0.05.  To evaluate whether the 
spike antigen IgG response level exceeded a specified threshold, logistic regression models were 
utilized.  Again, unadjusted (bivariate) models were developed for each predictor. Additionally, a 
parsimonious model was determined utilizing multivariate regression modeling incorporating a 
backward selection strategy with significance level-to-stay specified as α=0.05.  SAS v9.4® was 





Basic Demographics:  
This study included N=995 soldiers from the Connecticut Army and Air National Guard 
(Table 1). The racial composition was 7.7% African Americans, 2.5% Asian, 3.9% mixed, and 
72.5% white individuals. Race data was not available for N=120 (12.1%) individuals who 
provided only information on ethnicity (Hispanic). The study group’s age distribution was 
slightly shifted to the left compared to the working civilian population in CT (13) and contained 
predominately younger individuals (Figure 6). Similar to the overall US military population the 
study group was largely (79.2%) male and healthy (14). None of the participants were 
hospitalized with COVID-19 like illness since the onset of the SARS-CoV-2 pandemic.  
 
SARS-CoV-2 Serology Results and Demographic Associations:  
A total of N=103 (10.3%) of the subjects tested positive for SARS-CoV-2 spike antigen 
serum IgG, a rate 2.5-fold higher than the regional population at that time (15). Unadjusted 
logistic regression models (Table 1) demonstrated significant (p < 0.024) associations of SARS-
CoV-2 IgG positivity with race and ethnicity, with notably increased odd ratios for black and 
Hispanic individuals (OR 2.1, 95% CI 1.2-4.1, and OR 1.7; 95% CI 1.1-2.8). Significant 
association of SARS-CoV-2 IgG positivity was also observed with household size ≥	6 (p < 
0.005) and known exposure to COVID-19 (p < 0.009), but not with specific lifestyle habits, 
tobacco use, vaping or alcohol consumption/frequency. In a parsimonious adjusted logistic 
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regression model SARS-CoV-2 IgG positivity remained significantly associated with race, 
household size and known exposure to COVID-19 (p < 0.017, 0.012, and 0.008 respectively).  
Linear regression analysis of the data (Table 3) with SARS-CoV-2 IgG ELISA OD 
values quantitated as a continuous variable yielded stronger associations vs. logistic analysis 
with race, ethnicity, household size, and known COVID-19 exposure. Linear regression analysis 
further revealed a significant association of SARS-CoV-2 IgG levels with gender (p < 0.0002). 
While males were not more likely to be SARS-CoV-2 IgG positive than females, when they were 
positive, they had significantly (p<0.001) higher SARS-CoV-2 IgG ELISA OD values, on 
average by 0.25 OD units (Figure 1). Race, household size, known COVID-19 exposure, and 
gender remained significantly associated with SARS-CoV-2 IgG levels after parsimonious 
adjustment of linear regression models (Table 4).   
 
SARS-CoV-2 Serology Results and Occupational Associations:  
We further evaluated potential associations of SARS-CoV-2 serum IgG with exposures 
that might be connected to work, using military operation specialty (MOS) codes to define job 
title and related duties. Greater than two-thirds of the troops belonged to MOS groups that 
contained N > 7 people. Logistic and linear regression analysis demonstrated significant 
associations of SARS-CoV-2 IgG (p <0.016 and p < 0.002 respectively) with MOS codes 2T and 
92F (Fig. 2 and Fig. 7). MOS 2T performs and manages activities related to transportation by 
ground and air, while MOS 92F is a fuel specialist for both ground and air transport. Troops with 
MOS codes 2T and 92T come in contact with individuals and cargo from around the US and the 
world via air transport. MOS 2T and 92F remained significantly associated with SARS-CoV-2 
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serum IgG levels after parsimonious adjustment of linear regression models, accounting for 
demographic associations (Table 4).   
Among those subjects that held MOS codes with N < 6 persons it was notable that 2 of 2 
subjects with MOS code 155E (C-12 fighter pilots) were SARS-CoV-2 IgG positive, as were 
several subjects with MOS codes for nursing subspecialties, MOS 66-68 (Supplemental 
Materials Fig S2). However, the low number of subjects with the corresponding MOS codes 
lacked statistical power to attribute significance to the observed associations with MOS 155E or 
66-68.   
 
SARS-CoV-2 Serology Results and Geolocation:  
The distribution of SARS-CoV-2 IgG positivity throughout CT state was visualized 
based on zip code as shown in Figure 3. The notable hot spots were in Stamford, the 1st major 
city north of New York City (NYC), the northern part of the state near the international airport, 
and the zip codes for Bristol, Bridgeport and Waterbury; areas in CT’s upper quartile for 
population density and diversity, but lower quartile for median household and per capita income. 
The data are consistent with NYCs concomitant outbreak and the socioeconomics of COVID-19, 
and further suggest association of infection with travel, given the number SARS-CoV-2 IgG 
positive cases near the airport/interstate highway, and the association with MOS codes 2T and 
92F.   
 
SARS-CoV-2 neutralization capacity of serum:  
SARS-CoV-2 serum neutralizing capacity of non-hospitalized individuals with mild or 
asymptomatic COVID-19 is relatively understudied vs. that of hospitalized patients with more 
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severe disease (16). We measured the neutralizing ability of serum from a subgroup of subjects 
(N=12) with positive SARS-CoV-2 IgG test results in a live viral plaque assay. As shown in Fig. 
4, all twelve subjects’ serum had significant neutralizing capacity with IC50s ranging from 1:15 to 
1:280. On average the subject’s serum neutralizing capacity was comparable, albeit lower, than 
that of hospitalized patients as we recently published (17). Notably, serum spike IgG ELISA 
levels (OD) were closely related (r=.75) to the observed variability in IC50. 
 
Longevity of SARS-CoV-2 serum IgG:  
Persistence of SARS-CoV-2 IgG in serum was evaluated in a limited number of subjects 
that returned for repeat testing. Follow-up samples obtained 6 weeks to 5 months after the initial 
test showed no significant difference in average SARS-CoV-2 spike IgG serum levels compared 
to the initial time point (Fig. 5). However, the lack of change may be obscured by differences in 
time of sample collection relative to infection, as some subjects SARS-CoV-2 spike IgG serum 
levels decreased, while others increased.  Perhaps most notably, four subjects remained SARS-
CoV-2 spike IgG positive for greater than 7 months after the initial test, with sustained elevated 




Sero-surveillance of US National Guard troops from April 2020 to June 2020 
demonstrated a high prevalence (10.3%) of SARS-CoV-2 IgG compared to the local civilian 
population (4.1%) at the same time (15). SARS-CoV-2 spike antigen specific serum IgG was 
significantly associated with demographics and occupation, as defined by MOS code, and 
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clustered in distinct locations within the state. Serum from a subset of individuals tested was 
found to possess viral neutralizing capacity with IC50s between 1:15 and 1:280. In limited follow 
up samples, SARS-CoV-2 IgG serum levels remained elevated up to 7 months. Together the data 
demonstrate the development of protective adaptive humoral immune responses in working-age 
adults with mild/asymptomatic COVID-19 (not requiring hospitalization) and demonstrate the 
utility of sero-surveillance of healthy populations to identify at risk subgroups that might benefit 
from target intervention.   
The occupational association of specific MOS codes (2T, 92F) with SARS-CoV-2 serum 
IgG, and the distribution of cases along major interstate highway and near the international 
airport, are consistent with ground and air travel as COVID-19 risk factors. MOS 2T is an Air 
Force MOS code for specialists in transport and vehicle management, while MOS 92F codes are 
for Army fuel supply specialists that interact with individuals traveling across the country and 
the world. Further support for a link between air travel and COVID-19 is the observation that 2/2 
C-12 (small commuter transport) pilots in the present study were SARS-CoV-2 IgG positive. 
Together the data highlight transportation-related occupations as important SARS-CoV-2 risk 
factors, independent of demographics.   
The association of spike serum IgG with transportation-related MOS codes fits with the 
geolocation data showing the highest number of SARS-CoV-2 IgG positive subjects near the 
international airport and along the major interstate highways. The geographic prevalence of 
SARS-CoV-2 seropositivity partially overlaps with, but was distinct from, locations of highest 
population density and/or percentage of National Guard troops. The geolocation data do not rule 
out potential for infections in less populated/unsampled areas but highlight geographical regions 
in the state where travel provides increased opportunity for viral transmission.   
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The present data are consistent with the high prevalence of SARS-CoV-2 among black, 
Hispanic, and socio-economically disadvantaged populations reported in numerous studies to 
date (18-21). The findings suggest that racial and ethnic COVID-19 risk factors for US military 
personnel are similar to the US civilian population. Recognition of these known racial and ethnic 
disparities is important for maintaining combat readiness and national security, in addition to 
equitable distribution of health care and preventative services.   
A distinct aspect of the present study is the focus on immune responses in healthy non- 
hospitalized working age adults with mild or asymptomatic disease (vs. the pathologic response 
of hospitalized COVID-19 patients with more severe clinical course). In healthy individuals’, 
adaptive humoral responses to SARS-CoV-2 are likely part of effective immunity, yet remain 
less studied than those of hospitalized patients (16). The present data demonstrate the viral 
neutralizing capacity of serum from a limited number of non-hospitalized asymptomatic healthy 
individuals (albeit with lower IC50s than hospitalized individuals) and demonstrate an association 
with spike antigen-specific IgG levels. Furthermore, in limited subjects for which follow-up 
serum samples were available, spike antigen specific IgG levels persisted and remain elevated up 
to 7 months. Thus, adaptive humoral immune responses in healthy working age adults with 
mild/asymptomatic COVID-19 serve as biomarkers of infection amenable to disease surveillance 
efforts and demonstrate an association with anti-viral activity.   
The strengths and weaknesses of this study should be realized when interpreting the 
findings’ significance. Strengths include the large study population (N=995), available 
occupation (MOS code) and demographic information, and the ability to follow individuals over 
time. Limitations of the study included the small sample (N=12) size tested for viral neutralizing 
capacity and at the 7-month time point (N=4), due to resource and sample availability. There was 
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overlap in the association of SARS-CoV-2 serum IgG with certain risk factors, however, 
occupational (MOS codes 2T, 92F) associations remained highly significant in parsimoniously 
adjusted logistic and linear regression models (Tables 2 and 3).  
In summary, serology of US National Guard troops deployed to help combat COVID-19 
during April-June 2020 demonstrate increased prevalence of SARS-CoV-2 spike antigen-
specific IgG compared to the local civilian population (15) in association with specific 
occupations and demographics. The results further demonstrate the neutralizing capacity of 
serum from subjects with mild/asymptomatic COVID-19, not requiring hospitalization, and 
persistence of spike antigen-specific IgG for up to 7 months in limited subjects. Together the 
data demonstrate the utility of SARS-CoV-2 sero-epidemiology to identify specific sub-
populations of the US National Guard at risk for COVID-19. The finding may extend to civilian 
populations and military forces in other countries, and to other infectious or otherwise 
immunogenic agents.     
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Parameter Level N Odds Ratio L95% U95% Pr > χ2
Asian 25 1.43 0.42 4.91
Black 77 2.19 1.16 4.12
Mixed 39 0.28 0.04 2.04
Other 7 1.75 0.21 14.73
Unknown 120 2.22 1.30 3.80
White 720 1 (Ref) - -
Hispanic 171 1.74 1.08 2.81
Not Hispanic 817 1 (Ref) - -
Yes 136 1.97 1.19 3.26
Maybe/No 852 1 (Ref) - -
6 or more 67 2.48 1.32 4.64
Less than 6 921 1 (Ref) - -
Age [years] per year 988 1.01 0.99 1.03 0.535
Current 77 1.05 0.50 2.19
Previous 279 0.71 0.43 1.16
Never 631 1 (Ref) - -
Current 66 1.64 0.81 3.34
Previous 88 1.31 0.67 2.57
Never 834 1 (Ref) - -
Yes - every day 29 1.01 0.29 3.57
Yes - weekly 289 0.69 0.38 1.24
Yes - monthly 398 1.29 0.79 2.11
No 272 1 (Ref) - -
Female 200 0.71 0.41 1.24
Male 788 1 (Ref) - -
Air Force 154 0.87 0.48 1.57
Unknown 96 1.21 0.63 2.31
Army 738 1 (Ref) . .
2T 7 3.60 0.69 18.82
92F 7 6.76 1.49 30.64










Number in Household 0.005
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Table 2 – Parsimonious (adjusted) logistic regression model of demographic/occupational data 








Asian 25 0.0921 0.5774 1.398 0.403 4.850 0.0255 0.8732
Black 77 0.5194 0.3726 2.143 1.117 4.111 1.9426 0.1634
Mixed 39 -1.4732 0.8736 0.292 0.039 2.173 2.8437 0.0917
Other 7 0.5437 0.9261 2.196 0.259 18.624 0.3446 0.5572
Unknown 120 0.5610 0.3411 2.234 1.293 3.862 2.7048 0.1000
White 720 0 (Reference) - 1 (Reference) - - - -
Hispanic 171
Not Hispanic 817 0 (Reference) - 1 (Reference) - - - -
Yes 136 0.3525 0.1323 2.024 1.205 3.399 7.1016 0.0077
Maybe/No 852 0 (Reference) - 1 (Reference) - - - -
6 or more 67 0.4118 0.1643 2.279 1.197 4.339 6.2812 0.0122
Less than 6 921 0 (Reference) - 1 (Reference) - - - -
Age [years] per year 988
Current 77
Previous 279
Never 631 0 (Reference) - 1 (Reference) - - - -
Current 66
Previous 88
Never 834 0 (Reference) - 1 (Reference) - - - -
Yes - every day 29
Yes - weekly 289
Yes - monthly 398
No 272 0 (Reference) - 1 (Reference) - - - -
Female 200
Male 788 0 (Reference) - 1 (Reference) - - - -
Air Force 154
Unknown 96
Army 738 0.0000 . 1 (Reference) . . . .
2T 7 0.3614 0.6292 4.095 0.759 22.102 0.3299 0.5657
92F 7 0.6871 0.6016 5.672 1.185 27.142 1.3043 0.2534














Odds Ratio Wald             Chi-
Square Pr > χ
2 Wald             Chi-
Square Pr > χ2Estimate
Parameter Level n
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Table 3 – Unadjusted linear regression model of demographic/occupational data and SARS-






Estimate Standard Error eestimate L95% U95% t Value Pr > |t| F Value Pr > F
Asian 25 0.0995 0.1740 1.1047 -0.2419 0.4410 0.57 0.5674
Black 77 0.3382 0.1002 1.4025 0.1416 0.5349 3.37 0.0008
Mixed 39 -0.0462 0.1406 0.9549 -0.3221 0.2298 -0.33 0.7427
Other 7 0.0838 0.3249 1.0874 -0.5537 0.7213 0.26 0.7964
Unknown 120 0.3331 0.0843 1.3953 0.1677 0.4986 3.95 <.0001
White 720 0 (Reference) - 1 (Reference) - - - -
Hispanic 171 0.1949 0.0724 1.2151 0.0528 0.3688 2.69 0.0072
Not Hispanic 817 0 (Reference) - 1 (Reference) - - - -
Yes 136 0.1942 0.0797 1.2143 0.0377 0.3506 2.44 0.0150
Maybe/No 852 0 (Reference) - 1 (Reference) - - - -
6 or more 67 0.2695 0.1092 1.3093 0.0552 0.4839 2.47 0.0138
Less than 6 921 0 (Reference) - 1 (Reference) - - - -
Age [years] per year 988 0.0050 0.0026 1.0050 0.0000 0.0101 1.95 0.0510 3.82 0.0510
Current 77 0.0409 0.1046 1.0418 -0.1643 0.2461 0.39 0.6956
Previous 279 -0.0660 0.0622 0.9362 -0.1880 0.0561 -1.06 0.2890
Never 631 0 (Reference) - 1 (Reference) - - - -
Current 66 0.0684 0.1107 1.0708 -0.1489 0.2857 0.62 0.5369
Previous 88 0.0907 0.0970 1.0949 -0.0998 0.2811 0.93 0.3504
Never 834 0 (Reference) - 1 (Reference) - - - -
Yes - every day 29 -0.0667 0.1691 0.9355 -0.3985 0.2651 -0.39 0.6933
Yes - weekly 289 -0.0946 0.0730 0.9097 -0.2379 0.0486 -1.30 0.1953
Yes - monthly 398 0.0022 0.0680 1.0022 -0.1312 0.1356 0.03 0.9741
No 272 0 (Reference) - 1 (Reference) - - - -
Female 200 -0.2648 0.0679 0.7673 -0.3980 -0.1317 -3.90 0.0001
Male 788 0 (Reference) - 1 (Reference) - - - -
Air Force 154 -0.1314 0.0765 0.8768 -0.2815 0.0186 -1.72 0.0859
Unknown 96 -0.0096 0.0928 0.9905 -0.1917 0.1726 -0.10 0.9180
Army 738 0 (Reference) . 1 (Reference) . . . .
2T 7 0.9166 0.3259 2.5009 0.2771 1.5562 2.81 0.0050
92F 7 0.7405 0.3259 2.0969 0.1009 1.3800 2.27 0.0233





Vaping Catgory 0.58 0.5584
Smoking Catgory 0.74 0.4774
Number in Household 6.09 0.0138
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Table 4 – Parsimonious (adjusted) linear regression model of demographic/occupational data 





Estimate Standard Error eestimate L95% U95% t Value Pr > |t| F Value Pr > F
Asian 25 0.1530 0.1710 1.1653 -0.18 0.4887 0.89 0.3713
Black 77 0.3893 0.1019 1.4760 0.19 0.5892 3.82 0.0001
Mixed 39 0.0147 0.1382 1.0148 -0.26 0.2859 0.11 0.9154
Other 7 0.1256 0.3186 1.1338 -0.50 0.7508 0.39 0.6936
Unknown 120 0.3808 0.0837 1.4635 0.22 0.5452 4.55 <.0001
White 720 0 (Reference) - 1 (Reference) - - - -
Hispanic 171
Not Hispanic 817 0 (Reference) - 1 (Reference) - - - -
Yes 136 0.2284 0.0779 1.2566 0.08 0.3813 2.93 0.0035
Maybe/No 852 0 (Reference) - 1 (Reference) - - - -
6 or more 67 0.2375 0.1070 1.2681 0.03 0.4474 2.22 0.0266
Less than 6 921 0 (Reference) - 1 (Reference) - - - -
Age [years] per year 988 0.0076 0.0026 1.0076 0.00 0.0126 2.94 0.0034 8.64 0.0034
Current 77
Previous 279
Never 631 0 (Reference) - 1 (Reference) - - - -
Current 66
Previous 88
Never 834 0 (Reference) - 1 (Reference) - - - -
Yes - every day 29
Yes - weekly 289
Yes - monthly 398
No 272 0 (Reference) - 1 (Reference) - - - -
Female 200 -0.2849 0.0671 0.7521 -0.42 -0.1532 -4.25 <.0001
Male 788 0 (Reference) - 1 (Reference) - - - -
Air Force 154
Unknown 96
Army 738 0.0000 . 1 (Reference) . . . .
2T 7 0.9565 0.3186 2.6025 0.33 1.5817 3.00 0.0027
92F 7 0.6412 0.3188 1.8988 0.02 1.2668 2.01 0.0445
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Figure 1. Spike antigen-specific serum IgG levels in males vs. females. The amount of spike 
antigen -specific IgG was quantitated based on ELISA OD values (Y-axis) and positive test 
results (OD > 0.356) are compared for males and females. * indicates significant (p < 0.023) 


































Figure 2. Spike antigen-specific IgG in serum from subjects with different MOS codes. The 
mean and standard error of spike IgG ELISA OD values are shown for subjects that belong to 
different MOS groups with N > 7 per MOS. * indicates significant (p < 0.017) difference vs. 
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Figure 3. Geolocation of SARS-CoV-2 IgG+ subjects according to home zip code. The number 
of SARS-CoV-2 IgG+ subjects per zip code was mapped based on home zip code. Note hot spots 
along the I-95 and I-91 interstate highways, Stamford, the town just north of NYC, Bristol, 
Bridgeport, Waterbury, and the north-central part of the state near the Hartford-Springfield 







Figure 4. Neutralizing capacity of serum from individuals with mild/asymptomatic COVID-19, not requiring 
hospitalization. (A) Serum was titrated in a live viral plaque assay to measure neutralization capacity (% inhibition 
of plaque formation) expressed on the Y-axis vs. serum concentration (X-axis). Different color line/symbol 
represents data from a single subject with ID# shown in key in upper right, and negative control (blue triangles). (B) 
Correlation between the IC50 (Y-axis) and the spike IgG ELISA OD values (X-axis). Each symbol represents the 
average of replicate data points from a single individual in key above. The best fit trend line (r2=0.567), 
log(y)=0.495x + 0.991. (C) Comparison of serum neutralizing activity, IC50 (Y-axis) of the present National Guard 
troops (NG) vs. hospitalized study subjects recently published (17). Each symbol represents data from a single 















Figure 6. Age distribution of study subjects vs. the local population. The % of workers (Y-axis) 
in different age ranges (X-axis) are depicted. Study subjects (blue bars) data from present study 










Figure 7. Spike antigen-specific IgG in serum from subjects with different MOS codes. The 
mean and standard error of spike IgG ELISA OD values are shown for subjects that belong to 
different MOS groups with N ≥ 7 per MOS. 
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